IrsiCaixa’s scientific activity search engine | 69 | IrsiCaixa

Filter by research group

Once -or twice- daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach.

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.

Once-daily dosing of nevirapine in HAART.

Once-daily dosing of nevirapine in HAART.

Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study.

Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.

Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.

Potencial de los inhibidores de la integrasa para deplecionar los reservorios o para impedir que se rellenen

Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients.

Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy

« first
‹ previous
…
65
66
67
68
69
70
71
72
73
…
next ›
last »

Promoted by:

'La Caixa' Foundation

Member of:

In cooperation with: